Incidence, Mortality, and Burden of Malaria and Its Geographical Distribution in Iran during 2002-2015
Background: This study aimed at estimating the incidence, mortality, burden, and geographical distribution of malaria between 2002 and 2015 in Iran.
Methods: DALYs index was used to estimate the burden of malaria. DALYs-related malaria was calculated using a method developed by (WHO) for investigating the Global Burden of Disease (GBD); it was calculated through adding Years of Life Lost (YLLs) due to premature death to Years Lived with Disability (YLDs).The data on the incidence and mortality were collected from the malaria surveillance system in the Center for Communicable Diseases Control (CCDC), Ministry of Health and Medical Education (MOHME).
Results: The incidence of malaria had a decreasing trend over the studied period and it reduced from 15378 cases in 2002 to 777 cases in 2015. Overall, 28 cases of mortality were observed between 2002 and 2015. In addition, disease burden decreased from 90.78 DALYs in 2002 to 22.38 DALYs in 2015.Overall, there were 949.2 DALYs due to malaria from 2002 to 2015. The incidence and burden of malaria were not equally distributed among all the provinces in Iran and some areas were suffering from the highest burden of the disease.
Conclusion: The incidence and burden of malaria have had a decreasing trend over the years of the study and Iran has little to do in order to eradicate malaria. Since the disease is not equally distributed among various provinces of Iran, health policymakers must direct health resources towards specific areas of the country (Sistan and Baluchistan, Kerman, and Hormozgan) with high concentration of cases of malaria.
2. World Health Organization (2016). Fact Sheet: World Malaria Report 2016. World Health Organization.
3. Kumar A, Valecha N, Jain T, Dash AP (2007). Burden of malaria in India: retrospective and prospective view. Am J Trop Med Hyg,77(6 Suppl):69-78.
4. World Health Organization (2016). 10 facts on malaria. World Health Organization.
5. World Health Organization (2015). General launches new malaria report.
6. World Health Organization (2016). Global technical strategy for malaria 2016–2030. World Health Organization, Geneva.
7. Leslie T, Nahzat S, Sediqi W (2016). Epidemiology and Control of Plasmodium vivax in Afghanistan. Am J Trop Med Hyg,95(6 Suppl):72-77
8. Alegana VA, Wright JA, Nahzat SMet al (2014). Modelling the incidence of Plasmodium vivax and Plasmodium falciparum malaria in Afghanistan 2006–2009. PLoS One, 9(7):e102304.
9. Khan SN, Ayaz S, Ali Iet al (2013). Burden of Malaria infection among Neonates in highly epidemic region of Khyber Pakhtunkhwa, Pakistan. Int J Adv Res Technol, 2(4):84-92.
10. Khattak AA, Venkatesan M, Nadeem MFet al (2013). Prevalence and distribution of human Plasmodium infection in Pakistan. Malar J, 12:297.
11. Al-Ghoury A, El-Hashimi W, Abul-Hab J (2006). Epidemiology of malaria and predictions of retransmission in Babylon governorate, Iraq. East Mediterr Health J, 12(3-4):270-79.
12. World Health Organization (2016). Epidemiological profile of malaria in Iran.
13. Salmanzadeh S, Foroutan-Rad M, Khademvatan S et al (2015). Significant decline of malaria incidence in southwest of Iran (2001–2014). J Trop Med, 2015:523767.
14. Donev D, Zaletel-Kragelj L, Bjegovic V, Burazeri G (2010). Measuring the burden of disease: disability adjusted life year (DALY). Methods and Tools in Public Health, 30:715.
15. Murray CJ, Vos T, Lozano Ret al (2012). Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380(9859):2197-223.
16. Haagsma JA, Graetz N, Bolliger Iet al (2016). The global burden of injury: incidence, mortality, disability-adjusted life years and time trends from the Global Burden of Disease study 2013. Inj Prev, 22(1):3-18.
17. Alonso PL, Brown G, Arevalo-Herrera Met al (2011). A research agenda to underpin malaria eradication.PLoS Med, 8(1):e1000406.
18. Rushby JF, Hanson K (2001). Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis. Health Policy Plan, 16(3):326-31.
19. Murray CJ, Lopez AD (1996). Evidence-based health policy: lessons from the Global Burden of Disease Study. Science, 274(5288):740-3.
20. Kassebaum NJ, Arora M, Barber RMet al (2016). Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388(10053):1603-58.
21. Vos T, Abajobir AA, Abate KHet al (2017). Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 390(10100):1211-59.
22. Gunda R, Chimbari MJ, Mukaratirwa S (2016). Assessment of Burden of Malaria in Gwanda District, Zimbabwe, Using the Disability Adjusted Life Years. Int J Environ Res Public Health, 13(2):244.
23. Iran Statistical Yearbook (2016). Statistical Center of Iran. https://www.amar.org.ir/english/Iran-Statistical-Yearbook
24. Sufi K, Khanjani N, Kamyabi F (2015). Study of malaria infection trend and the role of preventive interventions on malaria incidence in Sarbaz city, Sistan and Baluchestan province. Journal of Preventive Medicine, 2(3):66-56.
25. Abdalla SI, Malik EM, Ali KM (2007). The burden of malaria in Sudan: incidence, mortality, and disability–adjusted life–years. Malar J, 6:97.
|Issue||Vol 48 No Supple 1 (2019)|
|Incidence Mortality Disability adjusted life years Malaria Iran|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|